Insights & Resources

Weaver’s transaction advisory team highlights a recent success guiding a client through a contentious net working capital and earn-out dispute.

Weaver supported an aviation management firm with sell-side financial and tax assistance, saving the client over $1 million in post-close adjustments.

J.P. Morgan's Q1 2025 biopharma and medtech reports reveal larger deals, global growth and financial strategies shaping the life sciences industry.

Weaver’s Transaction Advisory Services team highlights a recent success story, guiding a client through an investment in a fast-casual restaurant.

Download our white paper to learn how to even begin to measure and report GHG emissions.

False claims for fuel tax credits land on the IRS’ Dirty Dozen list of tax scams. Learn about the risks and new filing requirements.

Explore ASC 805’s role in bringing clarity to business combinations — from fair value measurements to goodwill and beyond.

J.P. Morgan’s Q3 2024 Biopharma Report highlights robust venture investments, shifting licensing trends and a resurgence in IPO activity.

The Q3 2024 Medtech Report from J.P. Morgan spotlights heightened investments, mergers and public offerings, signaling a positive industry outlook.

Weaver has developed carbon accounting processes to determine our carbon footprint across Scope 1 and Scope 2 emissions.

Microsoft has reformed the calculation of its supply-chain emissions through innovative accounting to align with its carbon-negative 2030 goals. Learn more here.

With the implementation of the Canadian Clean Fuel Regulations (CFR) beginning in 2022, Canada added significant clean fuel requirements to the existing British Columbia Low Carbon Fuels Act (BC-LCFS).